ATP1A3 p.Arg756His

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO6_SupportingO7_SupportingO8_Supporting

The NM_152296.5(ATP1A3):c.2267G>A (p.Arg756His) variant causes a missense change involving the alteration of a conserved nucleotide. The gene ATP1A3 is a known oncogene (CancerMine: 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.000000687 (AC=1) in the gnomAD database across 1,455,136 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000903. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.82). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000645400: This variant disrupts the p.Arg756 amino acid residue in ATP1A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID:26400718, 27268479, 27634470, 27726050, 29066118, 29397530)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R756C: Pathogenic/Likely_pathogenic (ClinVar VariationId 425189, 2 stars) The variant has been observed in cBioPortal in 2 samples across 2 studies and 1 cancer type; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

ATP1A3
NM_152296.5 missense

Scores

16
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:19O:1

Conservation

PhyloP100: 7.82

Publications

42 publications found
Variant links:
Genes affected
ATP1A3 (HGNC:801): (ATPase Na+/K+ transporting subunit alpha 3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 3 subunit. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
ATP1A3 Gene-Disease associations (from GenCC):
  • alternating hemiplegia of childhood 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • ATP1A3-associated neurological disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen, Illumina
  • cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • developmental and epileptic encephalopathy 99
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dystonia 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • encephalopathy, acute, infection-induced
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_152296.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 6 pathogenic, 0 benign (OR vs. background: 65.0); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 9.14 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ATP1A3 NM_152296.5
MANE Select
HGVSc / HGVSpc.2267G>Ap.Arg756His
Exon rankExon 17 of 23
missense
Prot: NP_689509.1UniProt: P13637-1
ATP1A3 NM_001256214.2
HGVSc / HGVSpc.2306G>Ap.Arg769His
Exon rankExon 17 of 23
missense
Prot: NP_001243143.1UniProt: P13637-3
ATP1A3 NM_001256213.2
HGVSc / HGVSpc.2300G>Ap.Arg767His
Exon rankExon 17 of 23
missense
Prot: NP_001243142.1UniProt: P13637-2

Ensembl Transcripts

ATP1A3 ENST00000648268.1
MANE Select
HGVSc / HGVSpc.2267G>Ap.Arg756His
Exon rankExon 17 of 23
missense
Prot: ENSP00000498113.1UniProt: P13637-1
ENSG00000285505 ENST00000644613.1
HGVSc / HGVSpn.2267G>A
Exon rankExon 17 of 25
non_coding_transcript_exon
Prot: ENSP00000494711.1UniProt: A0A2R8YEY8
ATP1A3 ENST00000545399.6
TSL:2
HGVSc / HGVSpc.2306G>Ap.Arg769His
Exon rankExon 17 of 23
missense
Prot: ENSP00000444688.1UniProt: P13637-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
AF: 6.87e-7
AC:1
Hom:0
AN:1455136
Cov:34
GnomAD4 genome
Cov:32
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:36930
Showing 4 sources

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
7
-
-
not provided (7)
3
-
-
Alternating hemiplegia of childhood 2 (3)
3
-
-
Dystonia 12 (4)
2
-
-
ATP1A3-related disorder (2)
1
-
-
ATP1A3-associated neurological disorder (1)
1
-
-
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome (1)
1
-
-
Developmental and epileptic encephalopathy 99 (1)
1
-
-
Inborn genetic diseases (1)

Computational Scores

AlphaGenome AVI
Pathogenic30
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.58D
BayesDel_noAF
Pathogenic0.59
CADD
Pathogenic30
DANN
Pathogenic1.0
DEOGEN2
Uncertain0.77D
Eigen
Pathogenic0.91
Eigen_PC
Pathogenic0.74
FATHMM_MKL
Pathogenic0.99D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-7.4
GPN-Star score
N/A7.4
LIST_S2
Uncertain0.95D
M_CAP
Pathogenic0.87D
MetaRNN
Pathogenic0.99D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Pathogenic4.3H
PhyloP100
Pathogenic7.8
popEVE
Uncertain-5.0
PrimateAI
Pathogenic0.89D
PROVEAN
Uncertain-3.7D
REVEL
Pathogenic0.98
Sift
Pathogenic0.0D
Sift4G
Pathogenic0.0D
Varity_R
N/A0.66
VESM-3B
Benign-12
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.